Optimization of Species-Selective Reversible Proteasome Inhibitors for the Treatment of MalariaJOURNAL OF MEDICINAL CHEMISTRYIF6.82025-10-010PRE
Target protein identification in live cells and organisms with a non-diffusive proximity tagging system使用非扩散邻近标记系统在活细胞和生物体中鉴定目标蛋白ELIFEIF02024-12-270OA
Structure-Based Discovery and Development of Highly Potent Dihydroorotate Dehydrogenase Inhibitors for Malaria ChemopreventionJOURNAL OF MEDICINAL CHEMISTRYIF6.82024-12-230PRE
Identification of potent and reversible piperidine carboxamides that are species-selective orally active proteasome inhibitors to treat malariaCELL CHEMICAL BIOLOGYIF7.22024-08-012PRE
Pseudoenzyme contributions to enzyme function and regulation in polyamine metabolismJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92024-03-010PRE
Repurposed dihydroorotate dehydrogenase inhibitors with efficacy against drug-resistant Acinetobacter baumanniiPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12022-12-136OAAI
Potent Antimalarials with Development Potential Identified by Structure-Guided Computational Optimization of a Pyrrole-Based Dihydroorotate Dehydrogenase Inhibitor SeriesJOURNAL OF MEDICINAL CHEMISTRYIF6.82021-04-2028OAAI
Alternative pathways utilize or circumvent putrescine for biosynthesis of putrescine-containing rhizoferrinJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92021-01-0110OAAI
Lead Optimization of a Pyrrole-Based Dihydroorotate Dehydrogenase Inhibitor Series for the Treatment of MalariaJOURNAL OF MEDICINAL CHEMISTRYIF6.82020-04-0621OAAI
Identification and Mechanistic Understanding of Dihydroorotate Dehydrogenase Point Mutations in Plasmodium falciparum that Confer in Vitro Resistance to the Clinical Candidate DSM265ACS INFECTIOUS DISEASESIF3.82018-10-3035OAAI
Relief of autoinhibition by conformational switch explains enzyme activation by a catalytically dead paralogELIFEIF02016-12-1516OAAI
A Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Improved Drug-like Properties for Treatment and Prevention of MalariaACS INFECTIOUS DISEASESIF3.82016-10-0478OAAI
Tetrahydro-2-naphthyl and 2-Indanyl Triazolopyrimidines Targeting Plasmodium falciparum Dihydroorotate Dehydrogenase Display Potent and Selective Antimalarial ActivityJOURNAL OF MEDICINAL CHEMISTRYIF6.82016-05-2156OAAI
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malariaSCIENCE TRANSLATIONAL MEDICINEIF14.62015-07-15273OAAI
Fluorine Modulates Species Selectivity in the Triazolopyrimidine Class of Plasmodium falciparum Dihydroorotate Dehydrogenase InhibitorsJOURNAL OF MEDICINAL CHEMISTRYIF6.82014-06-13109OAAI
SAR-Based Optimization of a 4-Quinoline Carboxylic Acid Analogue with Potent Antiviral ActivityACS MEDICINAL CHEMISTRY LETTERSIF42013-04-2562OA
Inhibition of pyrimidine synthesis reverses viral virulence factor-mediated block of mRNA nuclear exportJOURNAL OF CELL BIOLOGYIF6.42012-02-0656OAAI
Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies Potent Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors with Clinical Candidate PotentialJOURNAL OF MEDICINAL CHEMISTRYIF6.82011-07-14267OAAI
Lead Optimization of Aryl and Aralkyl Amine-Based Triazolopyrimidine Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase with Antimalarial Activity in MiceJOURNAL OF MEDICINAL CHEMISTRYIF6.82011-05-12160OA
Novel Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase with Anti-malarial Activity in the Mouse ModelJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92010-10-01133OAAI